Locations:
Search IconSearch
June 18, 2015/Neurosciences

What Therapeutic Approach Is Best for Children with Hemiparesis?

Constraint-induced movement therapy vs. bimanual therapy

Henry-690×380

By Douglas Henry, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Constraint-induced movement therapy (CIMT) has been used for a decade to improve the active movement and functional abilities in an upper extremity (UE) that is weak secondary to stroke or cerebral palsy.

Many centers now offer intensive therapy sessions lasting two to six weeks with three hours of therapy per day, several days per week, for children with hemiparesis. The unaffected extremity is constrained, often with a cast, while the weaker limb is subjected to intensive forced use and sensory interventions, with an attempt to activate and strengthen specific muscle groups and improve coordination, motor planning and functional abilities.

Multiple studies demonstrate that this technique improves motor outcomes in children with hemiparetic cerebral palsy, with lasting benefit.

More recently there has been interest in bimanual therapy for hemiparesis, where there is no limb restraint and which focuses more on functional tasks requiring the use of both hands. The thinking is that this may result in more practical or functional gains when compared with CIMT. One randomized trial has shown improvements in the bimanual therapy group compared with a control group.

Comparison Studies Show Advantages for Each Approach

So an obvious question is whether one method is better than the other. A few studies have sought to compare CIMT to bimanual therapy. One multicenter study enrolled 39 patients in CIMT, 33 in bimanual therapy and 33 in standard occupational therapy.1 Not surprisingly, the CIMT group improved more in grasp, whereas the bimanual group increased in bimanual spontaneous use of play and in activities of daily living.

Advertisement

In another comparison study, both constraint and bimanual groups showed improvements that persisted at six months. However, the bimanual group demonstrated more progress toward goals on the Goal Attainment Scale than did the CIMT group.2

At Cleveland Clinic Children’s Hospital for Rehabilitation, we see benefits in both strategies and incorporate them into our management of children with hemiparesis.

Certainly, children should begin some intervention as soon as their hemiparesis is detected. However, we do not think an intensive CIMT program is appropriate until a child is at least 18 months and preferably 24 months of age, depending on his or her developmental level.

Age-related Therapy Modifications Aid Progress

Before that age, we begin a modified constraint program that incorporates a moderate amount of bimanual activity, thus promoting developmental progress. When we believe a child is ready for an intensive program, we bring him or her into the CIMT program and focus strictly on that philosophy.

In the CIMT program, children receive occupational therapy for three consecutive hours, five days a week, for three weeks. This includes pool therapy three times a week. They wear a cast on the unaffected arm until the last two days of the program.

At the end of this program, we see improvements in isolated movements, strength and coordination in the affected upper extremity. Then we return the child to standard outpatient therapy and a daily home activity program, where the focus is on both independent use of the affected limb and bimanual activities. For example, they are taught to open doors and turn on light switches only with their affected limb. They also practice using both extremities in functional tasks such as dressing. We often use a similar approach with good success in patients with unilateral UE weakness secondary to other conditions such as brachial plexus injury and hemispherectomy.

Advertisement

In summary, our belief is that bimanual training may be more relevant for lifelong functioning but that CIMT can boost a child’s bimanual abilities.

Parental Involvement in Therapy Is Essential

Regardless of the approach, in order to see long-term improvements in UE functioning, parents should view their commitment to their child’s therapy not as a several week process but as a several-year one. With our current knowledge of central nervous system plasticity, we know that the more an activity is practiced, the more the responsible neurologic pathways are strengthened, both functionally and structurally. Limited functional magnetic resonance imaging studies before and after constraint therapy support this.

But parents also must consider focusing considerable time on improving the functionality of their child’s weak limb at the expense of other developmental, recreational and educational activities and family time. As with any intervention, the clinician’s role is to help the parents make an educated decision.

Dr. Henry is Director of Developmental and Rehabilitative Pediatrics at Cleveland Clinic Children’s Hospital for Rehabilitation.

References

  1. Facchin P, Rosa-Rizzotto M, Visonà Dalla Pozza L, Turconi AC, Pagliano E, Signorini S, Tornetta L, Trabacca A, Fedrizzi E; GIPCI Study Group. Multisite trial comparing the efficacy of constraint-induced movement therapy with that of bimanual intensive training in children with hemiplegic cerebral palsy: postintervention results. Am J Phys Med Rehabil. 2011;90(7):539-553.
  2. Gordon AM, Hung YC, Brandao M, Ferre CL, Kuo HC, Friel K, Petra E, Chinnan A, Charles JR. Bimanual training and constraint-induced movement therapy in children with hemiplegic cerebral palsy: a randomized trial. Neurorehabil Neural Repair. 2011;25(8):692-702.

Advertisement

Advertisement

Related Articles

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

photo of woman looking anxious on a couch
February 22, 2024/Neurosciences/Neuromuscular
Success of POTS Treatment Reduced by Concurrent Anxiety

Guidance from an expert on distinguishing — and co-managing — the disorders

Ad